WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Site License Information Icon
Live Chat Live Help Software for Website

BioMarin Pharmaceutical Inc.- Strategy and SWOT Report

MarketLine, October 2011, Pages: 47

BioMarin Pharmaceutical Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.

Features:

- Detailed information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis
- An in-depth view of the business model of BioMarin Pharmaceutical Inc. including a breakdown and examination of key business segments
- Intelligence on BioMarin Pharmaceutical Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about BioMarin Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

BioMarin Pharmaceutical (BioMarin) is engaged in development and commercialization of biopharmaceuticals. The company select product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology and provide an opportunity to be first-to-market. The company primarily operates in the US. It is headquartered in Novato, California and employed 871 people as of January 21, 2011. The company recorded revenues of $376.3 million during the financial year (FY) ended December 2010, an increase of 15.9% over FY2009. The operating profit of the company was $0.5 million during FY2010, a decrease of 96.7% over FY2009. The net profit was $205.8 million in FY2010, as compared to a net loss of $0.5 million in FY2009.

Reasons to Purchase:

- Gain understanding of BioMarin Pharmaceutical Inc. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess BioMarin Pharmaceutical Inc. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on BioMarin Pharmaceutical Inc.’s business structure, strategy and prospects

Company Snapshot
BioMarin Pharmaceutical Inc.: Company Overview
BioMarin Pharmaceutical Inc.: Overview and Key Facts
BioMarin Pharmaceutical Inc.: Overview
BioMarin Pharmaceutical Inc.: Key Facts
BioMarin Pharmaceutical Inc.: Key Employees
BioMarin Pharmaceutical Inc.: Key Employee Biographies
BioMarin Pharmaceutical Inc.: Major Products and Services
BioMarin Pharmaceutical Inc.: Company History
BioMarin Pharmaceutical Inc.: Management Statement
BioMarin Pharmaceutical Inc.: Locations and Subsidiaries
BioMarin Pharmaceutical Inc.: Key Competitors BioMarin Pharmaceutical Inc.: Company Analysis
BioMarin Pharmaceutical Inc.: Business Description
BioMarin Pharmaceutical Inc.: SWOT Analysis
BioMarin Pharmaceutical Inc.: SWOT Overview
BioMarin Pharmaceutical Inc.: Strengths
BioMarin Pharmaceutical Inc.: Weaknesses
BioMarin Pharmaceutical Inc.: Opportunities
BioMarin Pharmaceutical Inc.: Threats
BioMarin Pharmaceutical Inc.: Corporate Financial Deals Activity
BioMarin Pharmaceutical Inc.: Financial Deals Overview
BioMarin Pharmaceutical Inc.: Targets and Partners
BioMarin Pharmaceutical Inc.: Top Deals 2007 -YTD-2012
BioMarin Pharmaceutical Inc.: Advisors
BioMarin Pharmaceutical Inc.: Top Legal Advisors
BioMarin Pharmaceutical Inc.: Mergers and Acquisitions
BioMarin Pharmaceutical Inc.: Corporate Venturing
BioMarin Pharmaceutical Inc.: Partnership BioMarin Pharmaceutical Inc.: Recent Developments
BioMarin Pharmaceutical Inc.: News and Events Summary
BioMarin Pharmaceutical Inc.: Contracts
BioMarin Pharmaceutical Inc.: Financial Deals
BioMarin Pharmaceutical Inc.: Financial Performance
BioMarin Pharmaceutical Inc.: Regulatory and Legal Events
BioMarin Pharmaceutical Inc.: Research & Development
BioMarin Pharmaceutical Inc.: Strategy and Operations Appendix
Contact Us
Methodology
Definitions
About Datamonitor List of Tables Table 1: BioMarin Pharmaceutical Inc.: Key Facts Table 2: BioMarin Pharmaceutical Inc.: Key Employees Table 4: BioMarin Pharmaceutical Inc.: Key Competitors Table 5: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM-) Table 6: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (TTM-) Table 7: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2008 - YTD-2012) Table 8: BioMarin Pharmaceutical Inc.: M&A Average Deal Size - Value (US$m) Table 9: BioMarin Pharmaceutical Inc.: Targets and Partners Table 10: BioMarin Pharmaceutical Inc.: Top Deals 2007 -YTD-2012 Table 11: BioMarin Pharmaceutical Inc.: Legal Advisor Ranking by Value (US$m) Table 12: BioMarin Pharmaceutical Inc.: M&A Volume and Value Trend (2008 - YTD-2012) Table 13: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (2008 - YTD-2012) Table 14: BioMarin Pharmaceutical Inc.: Corporate Venturing Volume and Value Trend (2008 - YTD-2012) Table 15: BioMarin Pharmaceutical Inc.: Corporate Venturing by Geography (2008 - YTD-2012) Table 16: BioMarin Pharmaceutical Inc.: Partnership Volume and Value Trend (2008 - YTD-2012) Table 17: BioMarin Pharmaceutical Inc.: Partnership Trend by Deal Type (2008 - YTD-2012) Table 18: BioMarin Pharmaceutical Inc.: News and Events Summary Table 19: BioMarin Pharmaceutical Inc.: Contracts Table 20: BioMarin Pharmaceutical Inc.: Financial Deals Table 21: BioMarin Pharmaceutical Inc.: Financial Performance Table 22: BioMarin Pharmaceutical Inc.: Regulatory and Legal Events Table 23: BioMarin Pharmaceutical Inc.: Research & Development Table 24: BioMarin Pharmaceutical Inc.: Strategy and Operations List of Figures Figure 1: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM-) Figure 2: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (TTM-) Figure 3: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2008 - YTD-201

Customers who bought this item also bought